Sara Assaf, MD

Sara Assaf, MD, is an assistant professor of pulmonary and critical care at the University of New Mexico School of Medicine.

Articles by Sara Assaf, MD

Weighing ICS Benefits vs Long-Term Systemic Side Effects in COPD: Sara Assaf, MD

ByLaura Joszt, MA,Sara Assaf, MD

October 20th 2025

Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation strategies, said Sara Assaf, MD.

Sara Assaf, MD

Articles by Sara Assaf, MD

Weighing ICS Benefits vs Long-Term Systemic Side Effects in COPD: Sara Assaf, MD

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Sara Assaf, MD

Articles by Sara Assaf, MD

Weighing ICS Benefits vs Long-Term Systemic Side Effects in COPD: Sara Assaf, MD

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention